The medical technology company Aerocrine AB has received SEK 1.500.000 for a groundbreaking R&D project carried out in cooperation with a German R&D partner company. The project is aimed at developing NIOX PAED-an innovative diagnostic and monitoring device for non-cooperative measurement of nitric oxide (NO) in children below the age of seven and other groups of non-cooperative patients. The project has its origin in an unmet clinical and diagnostic need to develop new asthma diagnostic methodology and device that will minimize the need of active patient cooperation while keeping NO measurement accuracy on the same level. GAEU wrote the grant application form and guided Aerocrine through the entire application process.
Date:Monday, 15 October 2012